SEATTLE, Jan. 2 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) will
release fourth quarter and full-year 2001 financial results on Wednesday,
January 23, 2002, after the close of U.S. financial markets. This
announcement will be made available on the Immunex website at
http://www.immunex.com , and on PRNewswire's website at
http://www.prnewswire.com .
Additionally, Immunex executives will host a conference call and live
audio webcast at 2:00 p.m. PST (5:00 p.m. EST) on January 23rd to discuss the
company's financial results. The dial-in number for the earnings call is
719.457.2693 (ask for the Immunex call). The live webcast and replay can be
accessed on the Immunex website at http://www.immunex.com/investor_fs3.html .
Replay of the webcast will be available through January 30th, 2002.
Immunex has also scheduled a presentation at an investor conference in
January 2002. For information about available webcasts and replays, visit the
"Investor" page, "Events" section on the Immunex Corporation website at
http://www.immunex.com/investor_fs3.html.
The summary of investor events for Immunex in January is as follows:
JP Morgan H&Q 20th Annual Healthcare Conference
January 8, 2002
San Francisco, CA
Immunex 4th Quarter/Full-Year 2001 Earnings
January 23, 2002
Seattle, WA (719-457-2693 -- ask for the Immunex call)
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: Except for the historical information contained herein, this news
release contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the SEC, including but not limited to risks described under the caption
"Important Factors That May Affect Our Business, Our Results of Operations and
Our Stock Price" within our most recently filed Form 10-Q. The
forward-looking statements contained in this news release represent our
judgment as of the date of this release. Immunex undertakes no obligation to
publicly update any forward-looking statements. An electronic version of this
news release -- as well as additional information about Immunex of interest to
investors, customers, future employees and patients -- is available on the
Immunex home page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html
CONTACT:
media, Josh Schroeter, +1-206-389-4335, or
investors, Mark Leahy, +1-206-389-4363, both of Immunex
Corporation
|
